Pharmacokinetic Profile of Carbaamazepine and Its Metabolites on Javanese and…

Carbamazepine (CBZ) is an anticonvulsant widely used for epilepsy treatment.. However, it is difficult to establish suitable dosage regimens for this drug because of the variation on its pharmacokinetics profiles. A lot of evidences indicate that ethnic differences may affect pharmacokinetics and hence dosage requirements. The study was conducted to document pharmacokinetic profile of CBZ and i…

Pharmacokinetic & pharmacodynamic data analysis: concepts and applications

Edition

4th ed

ISBN/ISSN

978-91-9765-1004

Collation

1254 p.; bibl, ilus.; 25 cm

Series Title

-

Call Number

QV 38 JOH 2010

Clinical pharmacokinetics and phamacodynamics: concepts and applications

Edition

4th ed

ISBN/ISSN

0-7817-5009-1

Collation

839 p.; bibl.; 24 cm

Series Title

-

Call Number

QV 38 MAL 2011

Clinical pharmacokinetics: concepts and applications

Edition

3rd ed

ISBN/ISSN

0-683-07404-0

Collation

601 p.; bibl.; 24 cm

Series Title

-

Call Number

QV 38 ROW 1995

Pharmacokinetics: a modern view

Edition

-

ISBN/ISSN

0-306-41810-X

Collation

531 p.; bibl.; 24 cm

Series Title

-

Call Number

QV 38 BEN 1984

Pharmacokinetic Interactions Between Rifampicin and Efavirenz in HIV-TB Coinf…

The increased percentage of patients with HIV-TB coinfection leads to inevitable interactions between rifapincin and efavirenz Efavirenz is a potent non-nucoside reverse transcripate inhibitor (NNRT) for the treatment of HIV infection. The use of this drug combination with rifampicin causes problem in determination of the optiml dosage of efavirenz when adminstered concomitanly with refapicin.E…

Clinical Pharmacokinetics

Edition

-

ISBN/ISSN

0 85369 571 7

Collation

262 p.; bibl; 23 cm.

Series Title

-

Call Number

QV 38 DHI 2006

Variability and Stereoselectivity in Pharmacokinetics, Metabolism and Effects…

Edition

-

ISBN/ISSN

-

Collation

350 p.; 24 cm; bibl; ilus

Series Title

-

Call Number

QV 38 SOO 1991

Interaksi Obat dan Beberapa Implikasinya

Drug-drug interactions can initiate undesirable or adverse effects. This could have a clinical implication and could also become serious health problems. Since a large number of drugs are introduced and marketed every year, new interactions between concomitant medications might possibly increase. The safety profile of drugs including the impacts of drug-drug interactions can be provided …

ORG 10172 Studies Contributing to Its Pharmacokinetic and Clinical Profile

Edition

-

ISBN/ISSN

-

Collation

117 p.; 24 cm; bibl; ilus

Series Title

-

Call Number

QV 38 STI 1992